ALBUMEDIX

Serial Number 79200649
Registration 5830507
700

Registration Progress

Application Filed
Aug 15, 2016
Under Examination
Approved for Publication
May 28, 2019
Published for Opposition
May 28, 2019
Registered
Aug 13, 2019

Trademark Image

ALBUMEDIX

Basic Information

Serial Number
79200649
Registration Number
5830507
Filing Date
August 15, 2016
Registration Date
August 13, 2019
Published for Opposition
May 28, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 13, 2019
Registration
Registered
Classes
001 005 042

Rights Holder

Sartorius Albumedix Limited

98
Address
HQ, Mabel Street
GB

Ownership History

Albumedix A/S

Original Applicant
84
DK

Albumedix A/S

Owner at Publication
84
DK

Albumedix A/S

Original Registrant
84
DK

Albumedix Ltd

New Owner After Registration #1
99
GB

Sartorius Albumedix Limited

New Owner After Registration #2
98
GB

Legal Representation

Attorney
Daniel M. Gurfinkel

USPTO Deadlines

Next Deadline
1007 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-08-07)
Due Date
August 07, 2028
Grace Period Ends
February 07, 2029

Application History

50 events
Date Code Type Description Documents
Aug 13, 2025 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Jul 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 24, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 24, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 16, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 16, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 16, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 16, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2025 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Aug 13, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Apr 2, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 29, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 22, 2021 INNA R INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Loading...
Sep 26, 2021 INPR P PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Apr 23, 2021 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jan 29, 2021 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Jan 26, 2021 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Jan 26, 2021 PLGL A ASSIGNED TO PARALEGAL Loading...
Oct 31, 2020 LIMN I LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Oct 24, 2020 FINP P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Aug 7, 2020 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Jul 3, 2020 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Jul 3, 2020 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Jun 24, 2020 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Mar 5, 2020 IRRH M IRREGULARITY FROM IB EXAMINED BY MPU Loading...
Jan 23, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Jan 16, 2020 IRFI M IRREGULARITY ON FINAL DECISION RECEIVED FROM IB Loading...
Dec 6, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Dec 6, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Nov 13, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Aug 13, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 28, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 28, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 8, 2019 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 8, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 8, 2019 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Apr 24, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 24, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 24, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 24, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 24, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 19, 2019 CRTP C REG. CANCELLED - RESTORED TO PENDENCY Loading...
Mar 18, 2019 RCII I REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED Loading...
Mar 14, 2019 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 12, 2019 APET A ASSIGNED TO PETITION STAFF Loading...
Mar 12, 2019 APET A ASSIGNED TO PETITION STAFF Loading...

Detailed Classifications

Class 001
Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents
Class 005
Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for pharmaceutical medicinal use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin sold as an integral component of a vaccine and pharmaceuticals for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic agents for medical imaging [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient ]
Class 042
Research and development services relating to pharmaceutical products

Additional Information

Other
In the Statement, class 5 has been corrected per the Restriction dated January 17, 2019, and the Fnote dated January 26, 2019.
Other
In the Statement, class 5 has been corrected per the Restriction and the Fnote dated January 22, 2021.

Classification

International Classes
001 005 042